Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a flat day for the U.S. markets although all major averages hit record all-time highs in the session. Crude oil continued to fall, this time below $50, and it looks like oil…
Wednesday was a flat day for the U.S. markets although all major averages hit record all-time highs in the session. Crude oil continued to fall, this time below $50, and it looks like oil…
CytomX Therapeutics shares made a solid gain in Wednesday’s session following announcement of a strategic collaboration with Amgen in immuno-oncology.
Office Depot saw its shares dip on Wednesday after the firm announced that it would be changing its business model and taking a new strategic direction.
Tesla is perhaps one of the most favorite cult stocks in the market today. It has consistently posted losses year after year, yet investors still flock to this company.
Amicus Therapeutics is another biotech player seeing a nice boost from the World Muscle Society Conference in France.
Catabasis Pharmaceuticals shares continued their incredible climb after the announcement of positive efficacy results from its MoveDMD trial in a late-breaking session at the World Muscle Society Conference in France.
Finally some good news out of Mylan, which potentially is bringing the shares back to about even for 2017.
Tuesday was another positive day for the U.S. markets with all of the major averages hitting record all-time highs in the session. Crude oil continued to back off and looking like it might not…
Urban Outfitters watched its shares pull back on Tuesday after the retailer received a downgrade from Deutsche Bank.
Not only have GM shares hit an all-time high, but Merrill Lynch is taking a very bullish stance on the stock with the highest target on Wall Street.
PepsiCo is scheduled to release its most recent quarterly results before the markets open on Wednesday.
Berkshire Hathaway is adding to its portfolio yet again. The firm announced that it has acquired an equity stake in the largest operator of travel centers in North America, Pilot Flying J.
Amazon.com's powerful e-commerce empire has long been a threat to retailers everywhere, but with its acquisition of Whole Foods this summer its presence is even more pronounced.
Monday was a positive day for the broad U.S. markets with all of the major averages hitting record all-time highs. Crude oil backed off to its lowest level since mid-September. The two best-performing sectors…
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Monday after the firm received an upgrade from Morgan Stanley. The driving force behind this upgrade is Sarepta’s Duchenne muscular dystrophy…
Endocyte kicked off the week with an incredible gain, making it one of the best, if not the best, performing stocks in Monday’s session.
PepsiCo is scheduled to report its most recent quarterly results later this week, but one key analyst isn’t exactly bullish on what the company may have in store.
Rigel Pharmaceuticals has suffered over the past year, but it seems this update may be the catalyst it has been looking for.
Online automotive marketplace CarGurus expects to price more than 9 million shares to result in an initial public offering valued up to around $162 million.
24/7 Wall St. has put together a preview of PepsiCo, Costco and a few major companies scheduled to report their quarterly results this coming week.